Source: Adapted From Horizon Magazine, Horizon: The EU Research & Innovation Magazine, Ian Le Guillou, May 15, 2020 2 years ago
COVID-19 Antibodies: Although transfusing antibodies from COVID-19 recovered patients into seriously ill patients could provide a fast treatment win, a more selective approach may both treat and prevent the disease.
In theory, a single, highly-effective antibody that is mass-produced like a drug could combine the benefits of antivirals and a vaccine for at-risk individuals such as health ...